Skip to main content

Clinical Experience

Established & Proven

Avance Clinical: Early Phase Specialists With Over 20 Years of Experience

“Avance Clinical’s experience combined with our high-touch approach to partnership and reputation for timely delivery of high-quality data will safeguard the development of your new drug.” 

– Yvonne Lungershausen, CEO

Avance Clinical is a full-service CRO for biotechs with a proven track-record for delivering clinical excellence in Australia, New Zealand, and North America. As the largest premium full-service CRO in Australia and North America, Avance Clinical specializes in delivering top-tier clinical trials that yield globally accepted data.

The company has more than two decades of deep clinical experience delivering high-quality trial data that is accepted by all the major regulatory agencies around the globe. Avance Clinical’s client base currently extends across APAC, North America, Canada, EU, and New Zealand.

Avance Clinical is a full service CRO with deep scientific knowledge and experience across a broad range of therapeutic indications. We are gene-therapy accredited in Australia and are early-phase specialists. 

Pre-clinical through to Phase I and Beyond

Avance Clinical offers pre-clinical consultancy services with their experienced ClinicReady team right through to Phase I and beyond clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes that are available in Australia and highly qualified sites and networks within the United States. With experience across more than 110 therapeutic indications, Avance Clinical can deliver world-class, high-quality, internationally accepted data suitable for FDA and EMA review.

Global Reach, Local Expertise:

Beyond our Australian roots, Avance Clinical has a proven track record of conducting successful trials on a global scale. Our team is adept at navigating the complexities of international regulatory frameworks, cultural nuances, and the specific challenges faced by biotech companies. Leveraging our extensive network, we bring together highly skilled and knowledgeable clinical research staff from around the world to contribute their expertise to our projects. We collaborate with sponsors, regulatory bodies, and research sites worldwide to ensure that our trials adhere to the highest standards of quality, ethics, and efficiency.

Therapeutic Excellence:

Avance Clinical’s therapeutic experience spans a broad spectrum, including but not limited to oncology, cardiovascular, central nervous system, infectious diseases, and rare diseases. Our deep understanding of these therapeutic areas, coupled with our scientific and regulatory expertise, positions us as a trusted partner for biotech sponsors seeking to bring new therapies to market.

Partner with Avance Clinical, where expertise meets innovation, and together, we can make a difference to develop new medicines, in areas of unmet patient need.

Over two decades of deep clinical research management experience

Avance Clinical has more than two decades of deep clinical experience delivering high-quality trial data that is accepted by all of the major regulatory agencies around the globe.

Approximately 96% of the work is supporting small to medium-sized biotechnology companies executing Phase 1 and Phase 2 trials. Avance Clinical’s client base currently extends across APAC, North America, Canada, EU, and New Zealand.

View Our Experience

Cardiovascular

Atrial fibrillation, hypertension, hypertrophic cardiomyopathy, peripheral artery disease

CNS

Alzheimer’s, amyotrophic lateral sclerosis, anxiety, autism, Duchenne muscular dystrophy, fragile X, Huntington’s disease, major depressive disease (MDD), meningitis, multiple sclerosis, myasthenia gravis, Parkinson’s disease, recovery after stroke, schizophrenia, treatment-resistant depression

Dermatology

Acne vulgaris, actinic keratosis, age-related macular degeneration, alopecia areata, atopic dermatitis, erythropoietic protoporphyria (EEP),  inflammatory skin diseases, polymorphous light eruption (PLE), psoriasis, solar urticaria

Sexual Disfunction & Disorders

Erectile Dysfunction

Haematology

Anaemia, iron deficiency anaemia

Infectious Diseases

COVID-19, hepatitis B, hepatitis C, human immunodeficiency virus, malaria, respiratory syncytial virus, severe bacterial infection

Metabolism & Nutritional Disorders

Acromegaly, alpha-1 antitrypsin deficiency (AATD), cystic fibrosis, Fabry disease, hypoandrogenism, rheumatoid arthritis, type I diabetes, type II diabetes

Musculoskeletal & Connective Tissue Disorders

Anti-fibrotic and anti-inflammatory, cervical dystonia, lumbosacral radiculopathy, muscle spasms, postmenopausal osteoporosis

Oncology

Haematological malignancies (including B-cell lymphoid, multiple myeloma), solid tumors (including renal, breast, colorectal, glioblastoma multiforma, ovarian, allcomers)

Ophthalmology

Glaucoma, macular degeneration

Otorhinolaryngology (ENT)

Eustachain tube dysfunction, otitis media with effusion

Pediatric/Neonatology

Preterm infants

Pain

Burns patients, chronic pain, neuropathic pain, non steroidal/non opioid analgesic, osteoarthritis, postherpetic neuralgia, sciatica

Respiratory, Allergy, Thoracic & Mediastinal Disorders

Asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis, non-CF bronchiectasis

Urology

Overactive bladder

Full Service CRO for Biotechs

With more than 300 CRO specialist experts in-house your study is in the best hands for success.

Award-Winning CRO

Avance Clinical has been recognized for the fourth consecutive year by Frost & Sullivan in 2023, being awarded the Best Practices Customer Value Leadership for Biotech’s award, for its continuous exceptional performance.

Innovative Technology for Data Compliance

Avance Clinical uses state-of-the-art technology and gold-standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, Zelta, Veeva and Medrio are just some of Avance Clinical’s technology partners.

The Australian Government R&D grant means up to 43.5% rebate on clinical trial spend
Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks
Globally accepted data
No IND required for clinical trials

Request a Proposal or Talk to our Team  CONTACT US

More benefits

Avance Clinical can leverage all the benefits of Australia and New Zealand’s clinical ecosystem to deliver your study

Almost half clinical costs

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Rapid Start-up

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

Start-up time

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

No IND

No IND required for clinical trials

GMP material

Full GMP material is not mandated for Phase I clinical trials

Gene-therapy accreditation

Avance Clinical is an accredited gene-therapy CRO

Seasonal studies

Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia and New Zealand's counter-flu and allergy seasons

FDA and global regulatory data compliance

Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track record in FDA compliant research

Rebate

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Start-up time

Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks

Capabilities

Full service CRO in Australia and New Zealand

An Experienced Team

Learn more about us here

360
Studies in the past 5 years
300
Experienced Team Members
18,000
Participants in the past 5 years
26
Years of experience

Ready To Partner with Us?

Contact Us